Navigation Links
Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
Date:4/23/2008

BETHESDA, Md., April 23 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced the start of a phase 1 clinical trial with its BiTE(R) antibody MT110. The study will explore the safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of MT110 in patients with lung and gastrointestinal cancers.

MT110 targets the epithelial cell adhesion molecule (EpCAM or CD326), which is highly expressed on colon, lung, breast, prostate, ovarian, gastric and pancreas cancers. Additionally, EpCAM has been found on cancer stem cells of colon, breast, prostate and pancreas cancers. Cancer stem cells are believed to cause metastases and recurrence of these cancers. MT110 is the second BiTE antibody in clinical trials, and the fourth clinical program in Micromet's product pipeline. The first BiTE antibody, MT103 (MEDI-538), is now in phase 1 and phase 2 clinical trials for the treatment of haematological cancers.

"BiTE antibodies enable the patients' own T cells to very efficiently eliminate tumor cells," comments Patrick Baeuerle, Chief Scientific Officer of Micromet, "In various experimental tumor models, we have demonstrated the high therapeutic potential of EpCAM-specific BiTE antibodies, and we are now looking forward to determining the safety and the therapeutic potential of MT110 in patients."

"Having obtained clinical proof of concept for our BiTE antibody technology with MT103 in haematological cancers, we are excited about exploring the potential of MT110 in treating solid tumors," comments Carsten Reinhardt, Chief Medical Officer of Micromet. "Based on its unique mode of ac
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
2. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
3. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
4. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
5. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
6. Micromet Announces Changes in Management Team
7. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
8. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
9. Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
10. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
11. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25 Abaxis, Inc. (Nasdaq:... point-of-care blood analysis systems, announced t...tive officer, will present at the 21st Annual Pipe...ember 2, 2009 at 2:00 p.m. ET. The conference will...City. ,, About Abaxis ,, Abaxis develops,...
(Date:11/25/2009)...v. 25 According to Millennium Rese...technology market intelligence, the nearly $3 bill...tinue to see rapid growth over the next five years...arkets for Trauma Devices 2010 report finds tha...next five years, with competitors introducing spec...
(Date:11/25/2009)...ov. 25 Cempra Pharmaceuticals Inc....dent and chief executive officer, will present at ...ce at 8:50 a.m. EST, December 1, 2009, at The New ... will provide an overview of the company,s two lea...t of drug-resistant pathogens including MRSA. ,...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Larry Fitzgerald Offers Advice for Parents With Struggling Readers 51495 1Larry Fitzgerald Offers Advice for Parents With Struggling Readers 51495 2Larry Fitzgerald Offers Advice for Parents With Struggling Readers 51495 3Larry Fitzgerald Offers Advice for Parents With Struggling Readers 51495 4Heavy Drinking Linked to Aggressive Prostate Cancer 51492 1Heavy Drinking Linked to Aggressive Prostate Cancer 51492 2Heavy Drinking Linked to Aggressive Prostate Cancer 51492 3Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapy 51487 1Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapy 51487 2
... Health Secretary Everette James today announced...illion will be awarded from Pennsylvania,s share o..., These competitive grants focus on specific resea...y the statewide Health Research Advisory Committee...008-09 are autism spectrum disorders (ASD) and ant...
...gland Journal of Medicine employs Quest Diagnostic..., Feb. 20 Testing of blood specimens may detect...re the chronic form of lymphocytic leukemia (CLL) ...urrent issue of the New England Journal of Medi...ing of cellular changes that characterize the earl...
Other Medicine Technology:Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 2Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 4Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 2Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 4
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
(Date:11/26/2009)...INCETON, N.J., Nov. 27 The diabete...le over the next 25 years and annual medical spend...n, up from $113 billion today, according to a stud...e . The National Changing Diabetes ® Progra...the analysis by a team from the University of Chic...
(Date:11/26/2009)...r thrill when on an emotional rollercoaster, study...News) -- Call it the fear factor meets the jubilan...ators -- especially those who root for the winning... closely contested match and victory was in doubt,..., Chew on that this Thanksgiving weekend as you,re...
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...ERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCall/ -...day announced that the company will host two inves..., December 7, 2009 - 9:00 a.m. CT/10:00 a.m. E...a presentations surrounding carfilzomib in relapse...at the 51st American Society of Hematology (ASH) A...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
... for expectant moms to drink, study says , ...ements may help mothers-to-be reduce the risk for ...ancy, Australian researchers report. , The study, ...amage to the fetus depends not only on the amount ...
...ng statement of Matthew L. Myers, President, Campa..., (Logo: http://www.newscom.com/cgi-bin/prnh/2008...gislation announced today in Virginia fails to pro...stead enact a comprehensive, statewide smoke-free ...
...Net Development Group, Inc. (the "Company") (Nasd...opment services, today announced that it will rele...l results on Wednesday, February 25, 2009, after m...provides a comprehensive range of services to the ...
... letter sent today to the U.S. Senate Leadership a...inance Committee, the Coalition to Protect Senior ...nt to the pending economic stimulus bill, S.1. The...ty standards, or reduces provider payments -- whic...
...ng is a statement by ADA President John S. Findley...eps. Bart Stupak (D-Mich.) and Candice Miller (R-M...der Act, (H.R. 903), a bill that would bolster Ame...he nation,s dentists. , , "This legislation, whic...
...ursesbooks.org, the publishing program of American...ternational Society of Nurses in Genetics has just...llenges associated with advances in genetics tech...cutting edge of understanding the causal factors o...
Other Medicine News:Health News:Zinc May Counter Effects of Alcohol in Early Pregnancy 2Health News:Virginia Leaders Should Reject Flawed Smoke-Free Legislation That Fails to Protect Everyone's Right to Breathe Clean Air 2Health News:PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009 2Health News:PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009 3Health News:PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009 4Health News:National Front Line Caregiver Group Urges Senate Leaders to Support Grassley Amendment Protecting Seniors' Care, Assuring Stability of Nation's Long Term Care Workforce 2Health News:Statement by ADA President John S. Findley on the Dental Emergency Responder Act Introduced Today by Reps. Stupak and Miller 2Health News:ANA and ISONG Co-Publish Genetics and Ethics in Health Care: New Questions in the Age of Genomic Health 2Health News:ANA and ISONG Co-Publish Genetics and Ethics in Health Care: New Questions in the Age of Genomic Health 3
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: